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PharmaceuticalsAbstract One titrimetric and two spectrophotometric methods are described for the determination
of rizatriptan benzoate (RTB) in bulk drugs and in tablets. The methods use N-bromosuccinimide
(NBS) as an analytical reagent, janus green (JG) and calmagite (CMG) as auxiliary reagents. All the
three methods are indirect in which the unreacted NBS is determined after the reaction between
RTB and NBS is judged complete by iodometric back titration (method A) or by reacting with a
ﬁxed amount of either janus green (method B) or calmagite (method C) followed by the measure-
ment of absorbance at 620 nm (method B) or 540 nm (method C). Titrimetry allows the determina-
tion of 1–10 mg of RTB and follows a reaction stoichiometry of 1:3 (RTB:NBS), whereas
spectrophotometric methods are applicable over the concentration ranges of 0.5–8.0 lg ml1 in
method B and 1.5–30.0 lg ml1 in method C. Method B with a calculated molar absorptivity of
3.03 · 104 L mol1 cm1 is the second most sensitive spectrophotometric method ever developed
for RTB. The quality control/assurance parameters such as limits of detection (LOD), quantiﬁca-
tion (LOQ) and Sandelle’s sensitivity values are also reported for the spectrophotometric method.
The accuracy and precision of the methods were studied on intra-day and inter-day basis. No inter-
ference was observed from common pharmaceutical adjuvants. Statistical comparison of the results
with a reference method showed excellent agreement, and indicates no signiﬁcant difference in accu-
racy and precision. The reliability of the methods was further ascertained by recovery studies via
standard addition procedures.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Rizatriptan benzoate (RTB) belongs to the group of
anti-migraine drugs which acts as a selective 5-hydroxytryp-
tamine1B/1D (5-HT1B/1D) receptor agonist and is chemically
described as N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-
1H-indole-3-ethanamine monobenzoate (Fig. 1). It has a weak
234 K.N. Prashanth, K. Basavaiahafﬁnity for other 5-HT receptor subtypes and was launched in
1998 for the acute treatment of migraine in adults (Goadsby,
1998). Migraine headache is recognized as a chronic disease
with episodic occurrences, typically characterized by recurrent
disabling attacks of severe headaches, autonomic nervous sys-
tem drug function and neurological aura symptoms. The effec-
tiveness of triptans, which are serotonin 5-HT1B/1D receptor
agonist drugs, in these conditions is due to their ability to
block the stimulated secretion of neuropeptides from trigemi-
nal nerves to break the nociceptive cycle of migraine. These
actions also include constriction of meningeal and cerebral
blood vessels (Gory et al., 2005; Oldman et al., 2002; William-
son et al., 1997).
Rizatriptan (RTB) is not ofﬁcial in any pharmacopoeia. A
survey of literature reveals that RTB has been estimated in hu-
man plasma by liquid chromatography–electrospray tandem
mass spectrometry, LC–MS/MS (Guo et al., 2006; Chen
et al., 2006) and high performance liquid chromatography with
ﬂuorescence detection (Qin et al., 2006; Chen et al., 2004) and
in human serum by LC–MS/MS (Vishwanathan et al., 2000).
Development of a rapid, sensitive and selective method for
the determination of RTB is essential for the analysis of drug
in bulk, in the drug delivery system and for release dissolution
studies. A few methods are found in the literature for the deter-
mination of RTB in pharmaceuticals and include UV-spectro-
photometry (Amol et al., 2009; Kumari et al., 2010; Vivek
et al., 2010; Altinoz et al., 2002), spectroﬂuorimetry (Altinoz
et al., 2002), HPLC when present alone (Zecevic et al., 2008;
Jocic et al., 2007) or in combination with other anti migraine
drugs (Sagar et al., 2010). A micro emulsion electro kinetic
chromatography (MEEKC) has also been developed for the
determination of RTB and its degradation products (Mahuzier
et al., 2001).
To the best of our knowledge, there are four reports on the
use of visible spectrophotometry for the assay of RTB in phar-
maceuticals. The ﬁrst report (Shanmukha Kumar et al., 2010)
is concerned with two methods based on either the formation
of an ion-pair complex between RTB and methyl orange which
is extracted into chloroform and measured at 420 nm or redox-
complexation reaction in which iron (III) is reduced by RTB
and the resulting iron (II) complexed with 2,20-bipyridyl before
measuring at 490 nm. The second report (Dannana and
Marothu, 2007) describes three methods. The ﬁrst method is
based on the oxidative coupling reaction between RTB with
2,6-dichloroquinone-4-chlorimide (DCQC) and the color
developed was measured at 610 nm. The second method mea-
sures the color produced at 530 nm when sulfonate group of
1,2-napthoquinone-4-sulphonic acid (NQS) replaces the iminoH
N
N
N
N
N
O OH
Figure 1 Structure of rizatriptan benzoate.group of the indole moiety of RTB. In the third method
oxidative coupling product of RTB with brucine in presence
of sodium metaperiodate was measured at 530 nm. The third
report (Shanmukha Kumar et al., 2011) consists of three meth-
ods. First method is based on oxidation followed by complex
formation reaction of RTB involving 1,10-phenanthroline, fer-
ric chloride and ortho phosphoric acid to form an orange red
colored chromogen which was measured at 510 nm. In the sec-
ond method, the blue colored chromogen formed by reduction
of FC-reagent in alkaline medium by RTB was measured at
610 nm. Third method is based on the measurement of color
at 425 nm, of an ion association complex formed between aliz-
arin red and RTB. Fourth report (Ramzia et al., 2011) renders
one method based on the formation of charge transfer complex
between RTB and 7,7,8,8 tetracyanoquinodimethane (TCNQ)
which was measured at 744 nm.
However, the reported methods, particularly those based
on chromatography are complex, require expensive experimen-
tal setup and skilled personnel and are inaccessible to many
laboratories in developing and under developed nations. In
contrast, visible spectrophotometry is considered as the most
convenient analytical technique in most quality control and
clinical laboratories. All the previously reported visible spec-
trophotometric methods suffer from one or the other disad-
vantage such as poor sensitivity, complicated experimental
setup and meticulous control of experimental variables; few
methods require a rigid pH control and tedious liquid–liquid
extraction step, some methods have a relatively narrow dy-
namic linear range whereas a few involve a heating step as ci-
ted in Table 1.
The present investigation aims to develop more sensitive
and cost-effective methods for the determination of RTB in
pure form and in dosage forms using titrimetric and spectro-
photometric techniques. The methods employ N-bromosuccin-
imide which acts as brominating agent, and two dyes janus
green B and calmagite as auxiliary reagents. The proposed
methods have been demonstrated to be superior to the re-
ported methods with respect to speed, simplicity, sensitivity,
cost effectiveness and eco-friendliness.
2. Experimental
2.1. Apparatus
A Systronics model 106 digital spectrophotometer with 1-cm
matched quartz cells was used for all absorbance
measurements.
2.2. Materials and reagents
Pharmaceutical grade rizatriptan benzoate (RTB) which is
reported to be 99.65% pure was received from Jubilant Life
Sciences Ltd., India. All pharmaceutical preparations were ob-
tained from commercial sources in the local market. All the re-
agents used were of analytical reagent grade and distilled water
was used throughout the investigation. N-bromosuccinimide
(NBS): an approximately 0.01 M solution was prepared by
dissolving about 1.8 g of NBS (SRL Research Chemicals,
Mumbai, India) in water with the aid of heat and diluted to
one liter water. The solution was standardized iodometrically
(Berka et al., 1965) and kept in an amber colored bottle and
Table 1 Comparison of the proposed and the existing visible spectrophotometric methods.
Sl. No. Reagent/s used Methodology kmax (nm) Linear Range, lg ml
1
and e, l mol1 cm1
Reaction
time,min
R marks Ref.
1. (a) Methyl orange Extracted ion-pair complex was
measured
420 10–50 (s= 1.02 · l04) 2 L ss sensitive, involves pH
c ntrol, extraction step
Shanmukha Kumar
et al. (2010)
(b) Ferric chloride, 2,20 bipyridyl Complex formed between
reduced Fe(II)and2,20 bipyridyl
measured
490 4–20 (s= 1.0 · l04) 5 L ss sensitive, heating required.
Multi step reaction
2. (a) 2,6-Dichloro quinone-4-
chlorimide(DCQC)
Oxidative coupling product
measured
610 5–25 NA NA L ss sensitive Dannana and
Marothu (2007)
(b) 1,2-Napthoquinone-4-
sulphonic acid(NQS)
Color produced by replacement
of imino group of RTB by
sulfonate group of NQS
measured
480 15–75 NA NA L ss sensitive
c) Brucine, sodium
metaperiodate
Oxidative coupling product
measured
530 8–40 NA NA L ss sensitive
3. a) Ferric chloride, 1,10-
phenanthroline
Complex formed with 1,10-
phenanthroline, ferric chloride
measured
510 2–10 (e= 3.85 · 104) 10 Heating required, multi step
r action, narrow linear range
Shanmukha Kumar
et al. (2011)
b) Folin–Ciocalteu reagent,
sodium hydroxide
Reduced FC-reagent was
measured
610 2–10 (e= 3.5 · l03) 5 L ss sensitive
c) Alizarin red Extracted ion-pair complex was
measured
425 4–20 (s= 5.4 · 103) 2 L ss sensitive involves pH
c ntrol, extraction step
4. 7,7,8,8 tetracyanoquinodimetha
ne (TCNQ)
Charge transfer complex
measured
744 10–100NR 15 L ss sensitive, heating required Ramzia et al. (2011)
5. NBS (a) JG Resulting color measured 620 0.5–8 (e= 3.03 · 104) 15 Highly sensitive, no heating or
e traction step
Present methods
(b)CMG 540 1.5–30 (e= 1.15 · 104) 15 I expensive instrumental setup,
u e of ecofriendly chemicals, and
a ueous system
NR: not reported; NA: not available; JG: janus green B; CMG: calmagite.
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236 K.N. Prashanth, K. Basavaiahstored in a refrigerator; and used in titrimetry. It was diluted
appropriately to get 80 and 320 lg ml1 NBS for use in
spectrophotometric method B and method C, respectively.
Solutions of hydrochloric acid (Merck, Mumbai, India; sp.
gr. 1.18) 2.0 M for method A and 1.0 M for both method B
and C, 10% potassium iodide (Merck, Mumbai, India),
0.02 M sodium thiosulphate (Sisco-chem Industries, Mumbai,
India, assay 98%), and 1% starch indicator GR (LOBA
Chemie, Mumbai, India) were prepared in water.
The solutions of janus green B (90 lg ml1) (LOBA Che-
mie, Mumbai, India) and calmagite (360 lg ml1) (LOBA
Chemie, Mumbai, India) were prepared by dissolving 9 mg
and 36 mg of the respective dyes in water and diluted to the
mark with water in two separate 100 mL calibrated ﬂasks for
the use in method B and method C, respectively.
2.3. Preparation of stock standard solution of RTB
A stock standard solution equivalent to 1.0 mg ml1 of RTB
was prepared by dissolving accurately weighed 100 mg of pure
drug in water and diluted to the mark in a 100 ml calibrated
ﬂask. This solution was used in titrimetric work. Another stock
solution equivalent to 200 lg ml1 of RTBwas prepared by dis-
solving accurately weighed 20.0 mg of pure drug in water and
diluting to the mark in a 100 ml calibrated ﬂask. The second
stock solution (200 lg ml1 RTB) was diluted appropriately
with water to get a working concentration of 20 and 60 lg ml1
of RTB for use in spectrophotometric methods B and C, respec-
tively. The standard solutions were kept in an amber colored
bottle and stored in a refrigerator when not in use.
2.4. Assay procedures
2.4.1. Titrimetry (method A)
A 10 ml aliquot of pure drug solution containing 1.0–10.0 mg
of RTB was accurately measured and transferred into a 100 ml
titration ﬂask. The solution was acidiﬁed by adding 5.0 ml of
2 M hydrochloric acid followed by the addition of 10 ml of
0.01 M NBS. The content was mixed well and the ﬂask was
kept aside for 15 min with occasional swirling. Then, 5 ml of
5% potassium iodide was added to the ﬂask and the liberated
iodine was titrated with 0.02 M sodium thiosulphate to a
starch end point. A blank titration was run under the same
conditions. The drug content in the aliquot was calculated
from the amount of NBS reacted.
2.4.2. Spectrophotometry using janus green B (method B)
Different aliquots (0.25, 0.50, 1.00, . . . 4.00 ml) of a standard
20 lg ml1 RTB solution were transferred into a series of
10 ml calibrated ﬂasks by means of a micro burette and the to-
tal volume was adjusted to 4.00 ml by adding adequate quan-
tity of water. To each ﬂask 1.0 ml of 1 M HCl and 1.0 ml of
NBS solution (80 lg ml1) were added, the last being mea-
sured accurately. The ﬂasks were stoppered, content mixed
and allowed to stand for 15 min with occasional shaking. Fi-
nally, 1 ml of 90 lg ml1 janus green solution was added (accu-
rately measured) and the volume was adjusted to the mark
with water and mixed well. The absorbance of each solution
was measured at 620 nm against a reagent blank after 5 min.
2.4.3. Spectrophotometry using calmagite (method C)
Varying aliquots (0.25, 0.5, 1.0, . . . 5.0 ml) of a standard
60 lg ml1 RTB solution were transferred into a series of10 ml calibrated ﬂasks by means of a micro burette and the to-
tal volume was brought to 5.0 ml by adding water. To each
ﬂask 1.0 ml each of 1 M hydrochloric acid and NBS solution
(320 lg ml1) were added by means of a micro burette. The
content was mixed well and the ﬂasks were kept aside for
15 min with intermittent shaking. Finally, 1.0 ml of
360 lg ml1 calmagite solution was added to each ﬂask, the
volume was adjusted to the mark with water, mixed well and
the absorbance measured against a reagent blank at 540 nm
after 5 min. In both spectrophotometric methods, a standard
graph was prepared by plotting the absorbance versus the con-
centration of RTB. The concentration of the unknown was
read from the calibration graph or computed from the regres-
sion equation derived using Beer’s law data.
2.4.4. Procedure for the assay of RTB in tablets
Twenty tablets were weighed accurately and ground into a ﬁne
powder. A quantity of the powder containing 100 mg of RTB
was accurately weighed into a 100 ml calibrated ﬂask, and
60 ml of water was added. The content was shaken for about
20 min; the volume was diluted to the mark with water, and ﬁl-
tered using a Whatman No. 42 ﬁlter paper. First, 10 ml portion
of the ﬁltrate was discarded, and a convenient aliquot was ta-
ken, and the assay was completed according to the titrimetric
procedure described earlier. The tablet extract containing RTB
at a concentration of 1 mg ml1 was then diluted stepwise with
water to obtain working concentrations of 20 lg ml1 and
60 lg ml1 in RTB for spectrophotometric method B and
method C, respectively. A convenient aliquot was then sub-
jected to analysis by spectrophotometric procedures described
above.
2.4.5. Placebo blank analysis
A placebo blank of the composition: talc (200 mg), starch
(100 mg), acacia (100 mg), methyl cellulose (200 mg), sodium
citrate (100 mg), magnesium stearate (200 mg), and sodium
alginate (100 mg) was made, and its solution was prepared as
described under ‘‘Procedure for the assay of RTB in tablets’’
and then subjected to analysis using the procedures described
above.
2.4.6. Procedure for the determination of RTB in synthetic
mixture
To the placebo blank of the composition described above,
100 mg of RTB was added homogenized, and transferred to
a 100 ml calibration ﬂask, and solution was prepared as de-
scribed under ‘‘Procedure for the assay of RTB in tablets’’.
The solution was mixed well and ﬁltered using a Whatman
No. 42 ﬁlter paper. The resulting solution was assayed
(n= 5) by titrimetry according to the procedures described
above. The synthetic mixture solution (1 mg ml1 of RTB)
was then diluted stepwise with water to obtain working con-
centrations of 20 lg ml1 and 60 lg ml1 in RTB for spectro-
photometric method B and method C, respectively. A
convenient aliquot was then subjected to analysis by using
the procedures described above.
3. Chemistry
N-bromosuccinimide contains unstably bound bromine and
is used for the bromination of organic compounds
(Rajendraprasad et al., 2011). In the reactions where NBS
NO
O
Br 3 HBrO NH
O
O
3 H2O+ +3 3
Hydrolysis of NBS to produce hypobromous acid/ monovalent bromine.
H
N
N
N
N
N
O OH
RTB
3 HBrO
H+
H
N
N
N
N
N
O OH
Br
Br
Br
Brominated RTB
3 H2O
Unreacted NBS
+ KI Method A
Liberated I2 titrated against thiosulphate
+ Janus green B
Method B
Unbleached color of Janus green B
measured at 620 nm
+ Calmagite
Method C
Unbleached color of Calmagite
measured at 540 nm
RTB + Known exess of NBS Reaction product of the drug + Unreacted NBS
H+
Scheme 1 Suggested reaction pathway for the bromination of RTB by NBS.
Figure 2 Absorption spectra for method B and method C. (Method B: i-6 lg ml1; ii-4 lg ml1; iii-2 lg ml1 RTB and iv-without RTB).
(Method C: i-18 lg ml1; ii-12 lg ml1; iii-6 lg ml1 RTB and iv-without RTB).
Sensitive and selective methods for the determination of rizatriptan benzoate 237was used as a brominating agent, the monovalent positive bro-
mine of the NBS (the bond between bromine and nitrogen is
polarized by the two neighbouring carbonyl groups) is respon-
sible for bromination. The formation of the monovalent bro-mine due to hydrolysis of NBS is as shown in Scheme 1. The
proposed methods are based on the bromination of the drug
by NBS in hydrochloric acid medium. The reaction between
RTB and NBS was found to occur in 1:3 (drug:NBS) stoichi-
0 20 40 60 80 100
0.30
0.32
0.34
0.36
0.38
0.40
0.42
0.44
0.46
0.48
0.50
0.52
0.54
0.56
0.58
0.60
A
bs
or
ba
nc
e
Time (min)
Method B
Method C
Figure 3 Study of reaction time between NBS and RTB
(6 lg ml1 for method B and 18 lg ml1 for method C) in
hydrochloric acid medium and stability of the coloured species
by measuring the absorbance of the unreacted JG and CMG after
reacting with NBS.
238 K.N. Prashanth, K. Basavaiahometric ratio. The suggested reaction pathway for the bromin-
ation of RTB is given in Scheme 1. The proposed methods are
indirect and the determination of residual NBS after allowing
the reaction between RTB and a measured amount of NBS go
to completion. The dyes JG and CMG are used to determine
the unreacted NBS in spectrometry whereas iodometric back
titration procedure was used in titrimetry.
4. Results and discussions
Method development: optimization of experimental variables.
4.1. Method A (titrimetry)
In the proposed titrimetric procedure, the quantitative nature
of reaction between RTB and NBS was checked by treating
(1.0–10.0 mg) of RTB with a measured excess of NBS in acid
medium and determining the residual NBS iodometrically
(Scheme 1). In the range studied (1.0–10.0 mg), the reaction
stoichiometry was found to be 1:3 (RTB:NBS) which is calcu-
lated by the equation:
n¼ volume of NBS reactedmolecular wieght of drugmolarity of NBS
mg of drug takenTable 2 Regression and analytical parameters.
Parameter Method B Method C
kmax (nm) 620 540
Beer’s law limits (lg ml1) 0.5–8.0 1.5–30.0
Molar absorptivity (e) l mol1 cm1 3.03 · l04 1.15 · 104
Sandell sensitivitya (lg cm2) 0.0129 0.0340
Limit of detection (LOD) (lg ml1) 0.28 0.48
Limit of quantiﬁcation (LOQ) (lg ml1) 0.86 1.47
Regression equation (Yb)
Intercept (a) 0.0043 0.0003
Slope (b) 0.0762 0.0296
Correlation coeﬃcient (r) 0.9996 0.9998
Standard deviation of intercept (Sa) 0.00466 0.0045
Standard deviation of slope (Sb) 0.00104 0.00027
a Limit of determination as the weight in lg per mL of solution, which corresponds to an absorbance of A= 0.001 measured in a cuvette of
cross-sectional area 1 cm2 and l= 1 cm.
b Y= a+ bX, where Y is the absorbance, X is concentration in lg mL1, a is intercept, and b is slope.
Table 3 Evaluation of intra-day and inter-day precision and accuracy.
Method RTB* taken Intra-day (n= 5) Inter-day (n= 5)
RTB founda %RSDb %REc RTB founda %RSDb %REc
Method A 4.00 4.05 1.25 1.18 4.08 1.31 1.28
6.00 5.96 1.16 0.63 6.02 1.25 0.87
8.00 7.88 0.94 1.54 7.94 1.04 1.70
Method B 2.00 2.04 0.78 1.77 2.07 1.10 1.81
4.00 3.94 1.07 1.39 3.96 1.12 1.51
6.00 5.94 0.43 0.95 5.98 0.66 1.37
Method C 6.00 5.95 0.74 0.80 6.04 0.96 1.13
12.00 12.11 0.82 0.91 12.09 1.12 1.36
18.00 17.79 0.70 1.15 18.03 0.93 1.29
* In method A, RTB taken/found are in mg and they are (lg mL in method B and C).
a Mean value of ﬁve determinations.
b Relative standard deviation (%).
c Relative error (%).
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Sensitive and selective methods for the determination of rizatriptan benzoate 239Hydrochloric acid was found to be an ideal medium for the
assay and the reaction stoichiometry was found to be unaf-
fected in the presence of 3 to 8 ml of 2 M HCl in a total volume
of 25 ml, and 5.0 ml was chosen as the optimum volume. The
bromination reaction was found to be complete and quantita-
tive in 15 min and contact time up to 30 min had no effect on
the stoichiometry or the results.
4.2. Methods B and C (spectrophotometry)
4.2.1. Absorption spectra
Many dyes are irreversibly destroyed to colorless species by
oxidizing agents in acid medium (Kolthoff et al., 1957). The
proposed spectrophotometric methods are based on the reac-
tion between RTB and measured excess of NBS and subse-
quent determination of the latter by reacting it with a ﬁxed
amount of either janus green B or calmagite dye, and measur-
ing the absorbance at 620 or 540 nm (Fig. 2). These methods
make use of the bleaching action of NBS on the dyes, the
decolorization being caused by the oxidative destruction of
the dyes. RTB when added in increasing concentrations to a
ﬁxed concentration of NBS consumes the latter and there will
be a concomitant decrease in the concentration of NBS. When
a ﬁxed concentration of either dye is added to decreasing con-
centrations of NBS, a concomitant increase in the concentra-
tion of dye is obtained. Consequently, a proportional
increase in the absorbance at the respective kmax is observed
with increasing concentrations of RTB. Fig. 2 illustrates the
absorption spectra of janus green B (method B) and calmagite
(method C) in hydrochloric acid medium.
4.2.2. Selection of reaction medium
The reaction between RTB and NBS was performed in differ-
ent acid media. Better results were obtained in hydrochloric
acid medium. The effect of acid concentration on the reaction
between RTB and NBS was studied by varying the concen-
tration of HCl keeping the concentrations of NBS and drug
ﬁxed. The reaction was found to be rapid yielding a constant
absorbance with maximum sensitivity and stability when the
HCl concentration was maintained in the range of 0.1–
0.3 M (1.0–3.0 ml of 1 M in a total volume of 10 ml) for
method B. The same acid concentration was found sufﬁcient
for the instantaneous reaction between unreacted NBS and
janus green B. Therefore, 1 ml of 1 M HCl in a total volume
of 10 ml was used throughout method B. Similarly, in meth-
od C constant absorbance was observed when the HCl con-
centration was maintained in the range of 0.1–0.4 M (1.0–
4.0 ml of 1 M in a total volume of 10 ml). Thus, 1 ml of
1 M HCl in a total volume of 10 mL was used throughout
method C.
4.2.3. Optimization of dye concentration
Preliminary experiments were performed to ﬁx the upper limits
of the JG and CMG that could produce a reasonably high
absorbance, and these were found to be 9 lg ml1 for JG in
method B and 36 lg ml1 for CMG in method C.
4.2.4. Optimization of NBS
To ﬁx the optimum concentration of NBS, different concentra-
tions of NBS were treated with a ﬁxed concentration
(9 lg ml1) of janus green B in method B and calmagite
(36 lg ml1) in method C in HCl medium and the absorbance
240 K.N. Prashanth, K. Basavaiahwas measured at 620 nm and 540 nm, respectively. A constant
and minimum absorbance resulted with 8 lg ml1 NBS in
method B and 32 lg ml1 NBS in method C. Hence, different
concentrations of RTB were treated with 1 mL of 80 lg ml1
NBS (method B) and 320 lg ml1 NBS (method C) in HCl
medium before determining the residual NBS the reaction
scheme illustrated earlier (Scheme 1). This facilitated the
optimization of the linear dynamic ranges over which the pro-
cedure could be applied for the assay of RTB.
4.2.5. Study of reaction time and stability of the colored species
Under the described experimental conditions, the reaction be-
tween RTB and NBS was complete in 15 min in both the meth-
ods (Fig. 3) at room temperature (28 ± 2 C). After the
addition of dye, the reaction between NBS and dye was instan-
taneous and the absorbance of the unreacted dye was stable for
at least 1 h, thereafter.
4.3. Method validation procedures
The proposed methods have been validated for linearity, sensi-
tivity, selectivity, precision, accuracy and recovery.
4.3.1. Linearity and sensitivity
Over the range investigated (1–10 mg), a ﬁxed stoichiometry of
1:3 (RTB:NBS) was obtained in titrimetry (method A), which
served as the basis for calculations. In spectrophotometry, un-
der optimum conditions a linear relation was obtained between
absorbance and concentration of RTB in the range of 0.5–
8.0 lg ml1 (method B) and 1.5–30.0 lg ml1 (method C).
The calibration graph is described by the equation:
Y ¼ aþ bX ð1Þ
(where Y= absorbance, a= intercept, b= slope and
X= concentration in lg ml1) obtained by the method of
least squares. Correlation coefﬁcient, intercept and slope for
the calibration data are summarized in Table 2. Sensitivity
parameters such as apparent molar absorptivity and Sandell’s
sensitivity values, as well as the limits of detection and quanti-
ﬁcation, were calculated as per the current ICH guidelines
(ICH guidelines, 2005) and compiled in Table 2. The results at-
test to the sensitivity of the proposed method. The limits of
detection (LOD) and quantiﬁcation (LOQ) were calculated
according to the same guidelines using the formulae:Table 5 Results of analysis of tablets by the proposed methods.
Tablet brand
name
Label claim
mg/tablet
Found (percent of lab
Reference
method
Rizora-5 5 99.89 ± 0.77
Rizora-10 10 100.17 ± 0.61
Tabulated t-value at the 95% conﬁdence level is 2.78.
Tabulated F-value at the 95% conﬁdence level is 6.39.
a Mean value of ﬁve determinations.LOD ¼ 3:3r=s and LOQ ¼ 10r=s ð2Þ
where r is the standard deviation of ﬁve reagent blank determi-
nations, and s is the slope of the calibration curve.
4.3.2. Precision and accuracy
In order to evaluate the precision of the proposed methods,
solutions containing three different amounts/concentrations
of the RTB were prepared and analyzed in ﬁve replicates.
The analytical results obtained from this investigation are sum-
marized in Table 3. The low values of the relative standard
deviation (% R.S.D) and percentage relative error (% R.E)
indicate the precision and accuracy of the proposed methods.
The percentage relative error is calculated using the following
equation:
% R:E ¼ found taken
taken
 
 100 ð3Þ
The assay procedure was repeated ﬁve times, and percent-
age relative standard deviation (% R.S.D) values were ob-
tained within the same day to evaluate repeatability (intra-
day precision), and over ﬁve different days to evaluate interme-
diate precision (inter-day precision).
4.3.3. Selectivity
The proposed methods were tested for selectivity by placebo
blank and synthetic mixture analyses. A convenient aliquot
of the placebo blank solution, prepared as described earlier,
was subjected to analysis by titrimetry and spectrophotometry
according to the recommended procedures. In all the cases,
there was no interference by the inactive ingredients present
in the placebo mixture.
A separate experiment was performed with the synthetic
mixture. The analysis of synthetic mixture solution prepared
above yielded percent recoveries which ranged from 98.65 to
101.9 with standard deviation of 0.79–1.46 in all the cases.
The results of this study indicate that the inactive ingredients
present in the synthetic mixture did not interfere in the assay.
These results further demonstrate the accuracy, as well as the
precision, of the proposed methods.
4.3.4. Robustness and ruggedness
To evaluate the robustness of the methods, volume of HCl was
slightly altered (5 ± 1 ml) with reference to optimum values inel claim ± SD)a
Proposed methods
Method A Method B Method C
100.9 ± 1.08 101.1 ± 1.14 99.46 ± 0
t= 1.72 t= 1.97 t= 0.80
F= 1.97 F= 2.19 F= 1.46
101.4 ± 0.84 99.78 ± 1.11 101.6 ± 1.01
t= 2.65 t= 0.69 t= 2.71
F= 1.90 F= 3.31 F= 2.74
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Sensitive and selective methods for the determination of rizatriptan benzoate 241titrimetry. However, in spectrophotometry, the reaction time
(after adding NBS, time varied was 15 ± 1 min) and volume
of HCl were slightly altered (1 ± 0.1 ml) in both B and C
methods. To check the ruggedness, analysis was performed
by four different analysts in all the three methods. The robust-
ness and the ruggedness were checked at three different drug
levels (4, 6, 8 mg in method A; 2, 4, 6 lg ml1 in method B
and 6, 12, 18 lg ml1 in method C). The intermediate preci-
sion, expressed as percent RSD, which is a measure of robust-
ness and ruggedness, was within the acceptable limits (0.69–
2.33%) as shown in Table 4.
4.3.5. Application to tablets
In order to evaluate the analytical applicability of the pro-
posed methods to the quantiﬁcation of RTB in commercial
tablets, the results obtained by the proposed methods were
compared to those of the reference published method (Altinoz
et al., 2002) by applying Student’s t-test for accuracy and the
F-test for precision. The reference method consisted of the
measurement of the absorbance of pure RTB and its tablet ex-
tract in water at 225 nm. The results (Table 5) shows that the
Student’s t- and F-values at a 95% conﬁdence level are lower
than the tabulated values, thereby conﬁrming good agreement
between the results obtained by the proposed methods and the
reference method, with respect to accuracy and precision.
4.3.6. Recovery studies
The accuracy and validity of the proposed methods were fur-
ther ascertained by performing recovery studies. Pre-analysed
tablet powder was spiked with pure RTB at three concentra-
tion levels (50%, 100% and 150% of that in tablet powder)
and the total was then determined by the proposed methods.
In all the cases, the added RTB recovery percentage values
ranged from 98.83% to 102.7% with a standard deviation of
0.07–1.88 (Table 6), indicating good recovery and absence of
interference from the co-formulated substances in the assay.
5. Conclusions
One titrimetric and two spectrophotometric methods were
developed and validated for the determination of rizatriptan
benzoate using NBS as brominating agent. The new approach
of utilizing NBS and calmagite as reagents in spectrophotom-
etry is the ﬁrst of such reports. Method B is the most sensitive
among the proposed methods. The proposed spectrophoto-
metric methods have two additional advantages of simplicity
of operations and low-cost instrument. All the methods make
use of very easily available and cheaper reagents which demon-
strates their cost-effectiveness and the procedures do not in-
volve any tedious sample preparation. The assay methods
involve less stringent control of experimental parameters such
as the stability of the colored species, time of analysis and tem-
perature independence. These advantages encourage the appli-
cation of the proposed methods in routine quality control
analysis of rizatriptan benzoate in pharmaceutical
formulations.
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